[pericarditis following 5-fluorouracil administration]

Rev Med Liege. 2015 Jul-Aug;70(7-8):360-6.
[Article in French]

Abstract

We report a case of pericarditis supervening after 5-fluorouracil infusion in a 52-year-old patient suffering from metastatic rectal cancer. Besides its well-known side-effects (mucitis, diarrhea, nausea, hematotoxicity), this molecule sometimes induces cardio-toxicity, which can take different clinical forms, pericarditis being one of the most uncommon. Several risk factors have been described and have to be kept in mind when initiating this therapy. Prevention may consist of close monitoring of patients considered at risk. Treatment of 5-FU induced cardiotoxicity basically consists in stopping the use of this drug and replacing it with another chemotherapy agent.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects*
  • Humans
  • Leucovorin / administration & dosage
  • Leucovorin / adverse effects
  • Male
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / adverse effects
  • Pericarditis / chemically induced*
  • Pericarditis / diagnostic imaging
  • Rectal Neoplasms / drug therapy
  • Ultrasonography

Substances

  • Antimetabolites, Antineoplastic
  • Organoplatinum Compounds
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol